Your browser doesn't support javascript.
loading
Anagrelide for Gastrointestinal Stromal Tumor.
Pulkka, Olli-Pekka; Gebreyohannes, Yemarshet K; Wozniak, Agnieszka; Mpindi, John-Patrick; Tynninen, Olli; Icay, Katherine; Cervera, Alejandra; Keskitalo, Salla; Murumägi, Astrid; Kulesskiy, Evgeny; Laaksonen, Maria; Wennerberg, Krister; Varjosalo, Markku; Laakkonen, Pirjo; Lehtonen, Rainer; Hautaniemi, Sampsa; Kallioniemi, Olli; Schöffski, Patrick; Sihto, Harri; Joensuu, Heikki.
Afiliação
  • Pulkka OP; Laboratory of Molecular Oncology, Research Programs Unit, Translational Cancer Biology, Department of Oncology, University of Helsinki, Helsinki, Finland.
  • Gebreyohannes YK; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Mpindi JP; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Tynninen O; Department of Pathology, Haartman Institute, University of Helsinki and HUSLAB, Helsinki, Finland.
  • Icay K; Research Programs Unit, Genome-Scale Biology, Medicum and Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Cervera A; Research Programs Unit, Genome-Scale Biology, Medicum and Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Keskitalo S; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
  • Murumägi A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Kulesskiy E; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Laaksonen M; MediSapiens Ltd., Helsinki, Finland.
  • Wennerberg K; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Varjosalo M; Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
  • Laakkonen P; Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland.
  • Lehtonen R; Research Programs Unit, Genome-Scale Biology, Medicum and Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Hautaniemi S; Research Programs Unit, Genome-Scale Biology, Medicum and Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Kallioniemi O; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Schöffski P; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven and Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Sihto H; Laboratory of Molecular Oncology, Research Programs Unit, Translational Cancer Biology, Department of Oncology, University of Helsinki, Helsinki, Finland.
  • Joensuu H; Laboratory of Molecular Oncology, Research Programs Unit, Translational Cancer Biology, Department of Oncology, University of Helsinki, Helsinki, Finland. heikki.joensuu@hus.fi.
Clin Cancer Res ; 25(5): 1676-1687, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30530703
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Inibidores da Agregação Plaquetária / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Inibidores da Agregação Plaquetária / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia